Quick Answer
SANUWAVE Health, Inc. reported Research And Development Expense of $1.35 million for the year ending 2025.
- SANUWAVE Health, Inc. showed an increase of +101.0% in Research And Development Expense from 2024 to 2025.
- This data is from SANUWAVE Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $708.3 thousand | Q1 2015: $634.6 thousand | Q2 2015: $456.8 thousand | Q3 2015: $569.1 thousand | Q1 2016: $310.0 thousand | Q2 2016: $476.2 thousand | Q3 2016: $266.5 thousand | Q1 2017: $260.3 thousand | Q2 2017: $437.9 thousand | Q3 2017: $266.8 thousand | Q1 2018: $238.5 thousand | Q2 2018: $328.8 thousand | Q3 2018: $622.2 thousand | Q1 2019: $261.0 thousand | Q2 2019: $307.3 thousand | Q3 2019: $299.9 thousand | Q1 2020: $287.0 thousand | Q2 2020: $265.0 thousand | Q3 2020: $432.0 thousand | Q1 2021: $354.0 thousand | Q2 2021: $272.0 thousand | Q3 2021: $297.0 thousand | Q1 2022: $166.0 thousand | Q2 2022: $171.0 thousand | Q3 2022: $157.0 thousand | Q1 2023: $131.0 thousand | Q2 2023: $139.0 thousand | Q3 2023: $165.0 thousand | Q1 2024: $163.0 thousand | Q2 2024: $195.0 thousand | Q3 2024: $161.0 thousand | Q1 2025: $208.0 thousand | Q2 2025: $194.0 thousand | Q3 2025: $345.0 thousand.
- Over the full 16 years of available data (2010 to 2025), SANUWAVE Health, Inc.'s Research And Development Expense has declined by 65.1%.
- Historical annual values: Fiscal year 2025: $1.35 million | Fiscal year 2024: $673.0 thousand | Fiscal year 2023: $579.0 thousand | Fiscal year 2022: $567.0 thousand | Fiscal year 2021: $1.10 million | Fiscal year 2020: $1.25 million | Fiscal year 2019: $1.18 million | Fiscal year 2018: $981.7 thousand | Fiscal year 2017: $1.29 million | Fiscal year 2016: $1.13 million | Fiscal year 2015: $2.17 million | Fiscal year 2014: $3.00 million | Fiscal year 2013: $2.30 million | Fiscal year 2012: $1.76 million | Fiscal year 2011: $2.73 million | Fiscal year 2010: $3.88 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: